Dynamic HIV/AIDS parameter estimation with application to a vaccine readiness study in Southern Africa

IEEE Transactions on Biomedical Engineering

Volumn 52, Issue 5, 2005, Pages 784-791

  Filter, R A ^a   Xia, X ^c   Gray, C M ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^c IEEE   (South Africa)

Author keywords

Bioengineering and medical systems; HIV AIDS physical parameters; Parameter estimation; Parameter variation; Set point estimation

Indexed keywords

DATASETS; HUMAN IMMUNODEFICIENCY VIRUS (HIV); PATIENTS; STANDARD OPTIMIZATION;

DATA PROCESSING; LEAST SQUARES APPROXIMATIONS; OPTIMIZATION; PARAMETER ESTIMATION; VACCINES;

VIRUSES;

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACCURACY; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BIOENGINEERING; CONFIDENCE INTERVAL; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEASUREMENT; MODEL; NONHUMAN; PHYSICAL PARAMETERS; PROCESS OPTIMIZATION; REGRESSION ANALYSIS; RELIABILITY; SOUTH AFRICA; T LYMPHOCYTE; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA, SOUTHERN; ANTI-HIV AGENTS; COHORT STUDIES; COMPUTER SIMULATION; DIAGNOSIS, COMPUTER-ASSISTED; DRUG THERAPY, COMPUTER-ASSISTED; HIV; HUMANS; IMMUNOTHERAPY, ACTIVE; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 18744366352     PISSN: 00189294     EISSN: None     Source Type: Journal    
DOI: 10.1109/TBME.2005.844274     Document Type: Article

References (23)

1. M. A. Nowak and R. M. May, Virus Dynamics: Mathematical Principles of Immunology and Virology. Oxford, U.K.: Oxford Univ. Press, 2000.
2. A. S. Perelson and P. W. Nelson, "Mathematical analysis of HIV-1 dynamics in vivo," in SIAM Rev., vol. 41, Jul. 1999, pp. 3-44.
3. D. D. Ho et al., "Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection," Nature, vol. 373, pp. 123-126, 1995.
4. X. Wei et al., "Viral dynamics in HIV-1 infection," Nature, vol. 273, pp. 117-121, 1995.
5. A. S. Fauci, G. Pantaleo, S. Stanley, and D. Weissman, "Immunopathogenic mechanisms of HIV infection," Ann. Intern. Med., vol. 124, pp. 654-663, 1996.
6. X. Xia and C. H. Moog, "Identifiability of nonlinear systems with applications to HIV/AIDS models," IEEE Trans. Autom. Control, vol. 48, no. 2, pp. 330-336, Feb. 2003.
7. A. M. Jeffrey, X. Xia, and I. Craig, "Identifiability of an extended HIV model," presented at the 5th IPAC Symp. 2003 Modeling and Control in Biomedical Systems, Melbourne, Australia, Aug. 21-23, 2003.
8. C. M. Gray, C. Williamson, A. Puren, M. Paximadis, X. Xia, R. Filter, L. Zijenah, H. Cao, L. Morris, E. Vardas, M. Colvin, G. Gray, J. McIntyre, S. Allen, D. Katzenstein, M. Mbizo, N. Kumwenda, T. Taha, S. A. Karim, J. Flores, and H. W. Sheppard, "Viral dynamics, CD4 counts and human leukocyte antigen types in subtype C human immunodeficiency virus type 1-infected individuals from Southern Africa: Significance for vaccine trials," in AIDS Research and Human Retroviruses, 2004.
9. Panel on Clinical Practices for Treatment of HIV Infection. (2001, Aug.) Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. [Online]. Available: http://www.hivatis.org
10. X. Xia, "Estimation of HIV/AIDS parameters," Automatica, vol. 39, pp. 1983-1988, 2003.
11. Guidelines for Laboratory Test Result Reporting of Human Immunodeficiency Virus Type 1 Ribonucleic Acid Determination, CDC Working group. (2001, Nov.). [Online], Available: http://www.cdc.gov/
12. D. Brown and P. Rothery, Models in Biology: Mathematics, Statistics and Computing. Chinchester, U.K.: Wiley, 1993.
13. A. S. Perelson, A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho, "HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time," Science, vol. 271, pp. 1582-1586, 1996.
14. D. J. Covert and D. Kirschner, "Revisiting early models of the host-pathogen interactions in HIV infection," Comments Theoretical Biol., vol. 5, no. 6, pp. 383-411, 2000.
15. + T-cells," Mathematical Bios., vol. 165, pp. 27-39, Feb. 2000.
16. A. M. Jeffrey and X. Xia, "Estimating the viral load response time after HIV chemotherapy," presented at the Africon'02 Control Conf., George, South Africa, Oct. 3-5, 2002.
17. A. M. Jeffrey, X. Xia, and I. Craig, "When to initiate HIV therapy: A control theoretic approach," IEEE Trans. Biomed. Eng., vol. 50, no. 11, pp. 1213-1220, Nov. 2003.
18. V. Müller, A. F. M. Marée, and R. J. D. Boer, "Small variations in multiple parameters account for wide variations in HIV-1 set points: A novel modeling approach," in Proc. Roy. Soc. Lond. B. Biol. Sci., vol. 268, 2001, pp. 235-242.
19. D. S. Callaway and A. S. Perelson, "HIV-1 infection and low steady state viral loads," Bull. Math. Biol., vol. 64, pp. 29-64, 2002.
20. D. C. Douek et al., "Changes in thymic functions with age and during the treatment of HIV infection," Nature, vol. 396, pp. 690-695, 1998.
21. J. W. Mellors, C. R. Rinaldo Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley, "Prognosis in HIV-1 infection predicted by the quantity of virus in plasma," Science, vol. 272, pp. 1167-70, 1996.
22. J. W. Mellors et al., "Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection," Ann. Intern. Med., vol. 126, pp. 946-954, 1997.
23. T. W. Schacker, J. P. Hughes, T. Shea, R. W. Coombs, and L. Corey, "Biological and virologic characteristics of primary HIV infection," Ann. Intern. Med., vol. 128, pp. 613-620, 1998.